BioMarin Pharmaceutical (1BMRN) Hedge Fund Trading Activity
Trend: ▲ Hedge Funds Increased Holdings by 1.8M Shares Last Quarter
Hedge Fund Holdings in 1BMRN
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Follow | |||||||
|---|---|---|---|---|---|---|---|
 Louis Moore Bacon | Moore Capital Management LP | New | 100.00% | $19,314,750 | 0.28% | ||
 John Hussman | Hussman Strategic Advisors Inc | Added | 50.00% | $1,872,045 | 0.45% | ||
 Ken Fisher | Fisher Asset Management LLC | Added | 11.23% | $2,097,284 | <0.01% | ||
 Mario Gabelli | Gamco Investors, Inc. ET AL | Not Changed | 0.00% | $781,504 | <0.01% | ||
 Joel Greenblatt | Gotham Asset Management LLC | Not Changed | 0.00% | $697,351 | <0.01% | ||
 Bill Manning | Manning & Napier Advisors LLC | Not Changed | 0.00% | $10,103 | <0.01% | ||
| Drew Phillips | Fortitude Family Office, LLC | Not Changed | 0.00% | $1,248 | <0.01% | ||
| John A. Gunn | Dodge & Cox | Reduced | -0.78% | $866,036,781 | 0.47% | ||
| Theofanis Kolokotrones | PRIMECAP Management Co | Reduced | -4.46% | $864,665,731 | 0.65% | ||
 Andreas Halvorsen | Viking Global Investors LP | Reduced | -27.46% | $358,775,106 | 0.95% |
FAQ
Which hedge funds hold BioMarin Pharmaceutical?
The hedge funds that hold the most shares in BioMarin Pharmaceutical are John A. Gunn, Theofanis Kolokotrones and Andreas Halvorsen.
Are hedge funds buying or selling IT:1BMRN?
In the last quarter hedge funds have Increased their holdings in BioMarin Pharmaceutical by 1.8M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in BioMarin Pharmaceutical stock?
Warren Buffet currently does not own shares in BioMarin Pharmaceutical.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
